Increased Retention of Cardiac Cells to a Glass Substrate through Streptavidin-Biotin Affinity.


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
13 Jul 2021
Historique:
received: 14 04 2021
accepted: 21 06 2021
entrez: 19 7 2021
pubmed: 20 7 2021
medline: 20 7 2021
Statut: epublish

Résumé

In vitro analysis of primary isolated adult cardiomyocyte physiological processes often involves optical imaging of dye-loaded cells on a glass substrate. However, when exposed to rapid solution changes, primary cardiomyocytes often move to compromise quantitative measures. Improved immobilization of cells to glass would permit higher throughput assays. Here, we engineer the peripheral membrane of cardiomyocytes with biotin to anchor cardiomyocytes to borosilicate glass coverslips functionalized with streptavidin. We use a rat cardiac myoblast cell line to determine general relationships between processing conditions, ligand density on the cell and the glass substrate, cellular function, and cell retention under shear flow. Use of the streptavidin-biotin system allows for more than 80% retention of cardiac myoblasts under conventional rinsing procedures, while unmodified cells are largely rinsed away. The adhesion system enables the in-field retention of cardiac cells during rapid fluid changes using traditional pipetting or a modern microfluidic system at a flow rate of 160 mL/min. Under fluid flow, the surface-engineered primary adult cardiomyocytes are retained in the field of view of the microscope, while unmodified cells are rinsed away. Importantly, the engineered cardiomyocytes are functional following adhesion to the glass substrate, where contractions are readily observed. When applying this adhesion system to cardiomyocyte functional analysis, we measure calcium release transients by caffeine induction at an 80% success rate compared to 20% without surface engineering.

Identifiants

pubmed: 34278138
doi: 10.1021/acsomega.1c02003
pmc: PMC8280672
doi:

Types de publication

Journal Article

Langues

eng

Pagination

17523-17530

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL131782
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL138488
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001997
Pays : United States

Informations de copyright

© 2021 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Circ Res. 2004 Sep 17;95(6):604-11
pubmed: 15308581
J Mol Cell Cardiol. 2004 Feb;36(2):241-55
pubmed: 14871552
J Physiol. 2015 Dec 1;593(23):5091-109
pubmed: 26377030
Biomacromolecules. 2004 May-Jun;5(3):822-7
pubmed: 15132667
Stem Cells Int. 2016;2016:4198790
pubmed: 27127519
Pharmacol Rev. 2020 Jan;72(1):320-342
pubmed: 31871214
Pflugers Arch. 1996 Apr;431(6):814-27
pubmed: 8927497
Cell Stem Cell. 2009 Jul 2;5(1):54-63
pubmed: 19570514
Blood. 2011 Dec 15;118(25):e184-91
pubmed: 22034631
Langmuir. 2009 Jun 16;25(12):6985-91
pubmed: 19505164
J Control Release. 2015 Feb 10;199:29-36
pubmed: 25481443
Mol Ther. 2010 Jul;18(7):1365-72
pubmed: 20389289
Br J Pharmacol. 2020 Oct;177(20):4581-4594
pubmed: 32767563
J Physiol. 2014 May 1;592(9):1949-56
pubmed: 24591576
Am J Physiol Heart Circ Physiol. 2013 Feb 1;304(3):H455-64
pubmed: 23203963
Langmuir. 2017 Jul 11;33(27):6778-6784
pubmed: 28605895
Curr Protoc Cell Biol. 2015 Mar 02;66:1.1.1-1.1.22
pubmed: 25727327
Cardiovasc Res. 2021 Feb 22;117(3):694-711
pubmed: 32365198
J Clin Invest. 2019 Feb 1;129(2):496-498
pubmed: 30614816
Chem Commun (Camb). 2011 Oct 7;47(37):10329-31
pubmed: 21853201
J Mol Cell Cardiol. 2011 Sep;51(3):288-98
pubmed: 21723873
Channels (Austin). 2012 May-Jun;6(3):166-73
pubmed: 22854599
Nat Med. 2018 Aug;24(8):1225-1233
pubmed: 29892068
Biomaterials. 2009 Aug;30(22):3702-10
pubmed: 19375791
Biomaterials. 2014 Jul;35(21):5627-35
pubmed: 24731711
Nature. 2002 Jan 10;415(6868):198-205
pubmed: 11805843
Cardiovasc Res. 1996 Aug;32(2):362-73
pubmed: 8796124
ACS Appl Mater Interfaces. 2015 Aug 19;7(32):17598-602
pubmed: 26244409
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Biomacromolecules. 2015 Feb 9;16(2):541-9
pubmed: 25592156

Auteurs

Kara A Davis (KA)

Department of Chemical and Materials Engineering, University of Kentucky, Lexington, Kentucky 40506, United States.

Jensen Z Goh (JZ)

Department of Physiology, University of Kentucky, Lexington, Kentucky 40536, United States.

Andrea H Sebastian (AH)

Department of Physiology, University of Kentucky, Lexington, Kentucky 40536, United States.

Brooke M Ahern (BM)

Department of Physiology, University of Kentucky, Lexington, Kentucky 40536, United States.

Christine A Trinkle (CA)

Department of Mechanical Engineering, University of Kentucky, Lexington, Kentucky 40506, United States.

Jonathan Satin (J)

Department of Physiology, University of Kentucky, Lexington, Kentucky 40536, United States.

Ahmed Abdel-Latif (A)

Gill Heart and Vascular Institute and Division of Cardiovascular Medicine, University of Kentucky and the Lexington VA Medical Center, Lexington, Kentucky 40506, United States.

Brad J Berron (BJ)

Department of Chemical and Materials Engineering, University of Kentucky, Lexington, Kentucky 40506, United States.

Classifications MeSH